| Sartorius AG | 300.80 / +0.77% |
| Date/Time | 07/03 / 17:29 |
| Chg. / Chg.(%) | 2.30 / +0.77% |
| Bid | 300.60 / 15 |
| Ask | 301.40 / 29 |
| Open | 298.20 |
| Previous Close | 298.50 |
| High | 303.80 |
| Low | 298.20 |
| Volume [EUR] | 1,152,253.00 |
| Volume [Units] | 3,822 |
| Price fixings | 310 |
| ISIN | DE0007165631 |
| Security | SRT3/D |
| Exchange | Cboe Europe CXE |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| Lang & Schwa.. | 300.800 |  |
|
| Xetra | 301.40 | |
40,976 |
| Cboe Europe .. | 300.80 | |
3,822 |
| TradeGate | 301.200 |  |
3,714 |
| Turquoise | 300.70 | |
3,505 |
| London Inter.. | 300.50 | |
3,429 |
| Cboe Europe .. | 300.70 | |
1,302 |
| Stuttgart | 301.200 | |
925 |
| gettex | 301.800 | |
108 |
| Düsseldorf | 301.20 | |
20 |
| Berlin | 303.00 | |
20 |
| Hamburg | 297.20 | |
3 |
| Frankfurt | 294.8000 |  |
0 |
| München | 296.20 | |
0 |
| Hannover | 294.80 | |
0 |
| SIX Swiss Ex.. | 343.20 | |
|
| Nasdaq Other.. | 338.0000 | 1 | |
| Vienna Globa.. | 304.00 | 0 | |
| EUREX | Options | ||
News
- XBiotech Announces Rapid Enrollment for its Randomized Multi-Center Clinical Study for Bermekimab in Patients with Hidradenitis Suppurativa
11/19/2019 / 14:55 - GlobeNewswire - Worldwide Cell Based Assay & High Content Screening Market Forecasts to 2024 - Candidate Growth, Immuno-oncology, Genomic Blizzard, Technology Convergence, The Insurance Effect
10/29/2019 / 11:55 - GlobeNewswire - XBiotech Announces First Patient Enrolled in Randomized Multi-Center Clinical Study Evaluating Bermekimab Therapy in Patients with Hidradenitis Suppurativa
10/23/2019 / 14:15 - GlobeNewswire - Global $1.78Bn Fermenters Market Outlook, 2025
10/23/2019 / 11:26 - GlobeNewswire - 2019 Report on Cell Harvesting: Market Projected to Grow by $157.2M During 2019-2025
10/22/2019 / 18:05 - GlobeNewswire
Real-time